SCHEMBL21595955

SCHEMBL21595955

Cc1ccc(OCCNC(=O)O)cc1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.73
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ KMT2A Q03164 4/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ POLB P06746 1/20 0.61
▸ MAPK1 P28482 2/20 0.60
▸ HSD17B10 Q99714 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ DRD2 P14416 3/20 0.59
▸ DRD4 P21917 3/20 0.59
▸ DRD3 P35462 3/20 0.59
▸ MTNR1A P48039 2/20 0.59
▸ MTNR1B P49286 2/20 0.59
▸ USP2 O75604 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ TSHR P16473 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171846 0.87 MTNR1A (0.75) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL21596070 0.87 MTNR1A (0.75) NPC1KMT2AMEN1MAPK1HSD17B10
Hydrochloric Acid SCHEMBL30832634 0.86 MTNR1A (0.73) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL807668 0.86 NPC1 (0.69) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL25268396 0.85 DRD4 (0.57) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL3446802 0.85 MTNR1A (0.73) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL5147840 0.84 USP2 (0.67) NPC1L3MBTL1POLBMAPK1HSD17B10
SCHEMBL10389706 0.84 NPC1 (0.67) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL7094090 0.84 MTNR1A (0.53) NPC1L3MBTL1KMT2AMEN1POLB
SCHEMBL3446997 0.84 SMN1; SMN2 (0.55) NPC1L3MBTL1KMT2AMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347568-A1 HETEROARYL DIAMIDE IRE1/XBP1S ACTIVATORS Protego Biopharma, Inc. (US) 2024-04-10 — — EP disclosed
WO-2019244066-A2 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2019-12-26 — — WO disclosed
Send feedback